alpha-fetoprotein conjugated thapsigargin (Alpha Cancer/The University Health Network)

N/A

Report date: 2025/01/26 18:34:46

Base Information

Drug Namealpha-fetoprotein conjugated thapsigargin (Alpha Cancer/The University Health Network)
Drug Alias NameACT-902
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAlpha-fetoprotein modulatorsProstate-specific antigen modulators
TargetsProstate-specific antigenAlpha-fetoprotein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlpha Cancer Technologies
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A